Exhibit 1

 

JOINT FILING AGREEMENT

 

The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned, and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe that such information is inaccurate.

 

Dated: February 14, 2025  
   
Commodore Capital LP  
     
By: /s/ Michael Kramarz  
Michael Kramarz, Managing Partner  
     
Commodore Capital Master LP  
     
By: /s/ Michael Kramarz  
Michael Kramarz, Authorized Signatory  

 

 

 

Nurix Therapeutics (NASDAQ:NRIX)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025 Nurix Therapeutics 차트를 더 보려면 여기를 클릭.
Nurix Therapeutics (NASDAQ:NRIX)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025 Nurix Therapeutics 차트를 더 보려면 여기를 클릭.